December 10, 2007 -- Helicon Group Limited (ASX: HCG) is an Australian company that seeks to partner with small to medium sized Western biopharmas and medical device companies to promote and sell products in China that meet currently unfilled needs in that market. The company made its IPO last year. As part of its services, Helicon will manage regulatory approvals in China, then organize distribution and use its sales and marketing team to promote the products. Today, the company announced an agreement with Jewim Pharmaceticals to distribute drugs to oncology departments in hospitals. More details...
